ВИЧ КАК НЕЗАВИСИМЫЙ ФАКТОР РИСКА СЕРДЕЧНО-СОСУДИСТЫХ ЗАБОЛЕВАНИЙ
- Авторы: ЧУКАЕВА И.И.1, КОМАРОВА И.В.1, КРАВЧЕНКО А.В.2, КУШАКОВА Т.Е.2
-
Учреждения:
- Российский национальный исследовательский университет им. Н.И. Пирогова
- ФБУН Центральный НИИ эпидемиологии Роспотребнадзора
- Выпуск: № 4 (2012)
- Страницы: 21-25
- Раздел: Статьи
- URL: https://journals.eco-vector.com/2226-6976/article/view/275879
- ID: 275879
Цитировать
Полный текст
Доступ предоставлен
Доступ платный или только для подписчиков
Аннотация
Ключевые слова
Полный текст
Об авторах
Ирина Ивановна ЧУКАЕВА
Российский национальный исследовательский университет им. Н.И. Пирогова
Email: chukaeva@mail.ru
д-р мед. наук, проф., зав. каф. поликлинической терапии № 2 лечебного фак-та 115280, Москва, ул. Велозаводская, д. 1/1
Ирина Владимировна КОМАРОВА
Российский национальный исследовательский университет им. Н.И. Пироговаассистент каф. поликлинической терапии № 2 лечебного фак-та Moscow
Алексей Викторович КРАВЧЕНКО
ФБУН Центральный НИИ эпидемиологии Роспотребнадзорад-р мед. наук, проф., вед. науч. сотр. СНИО эпидемиологии и профилактики СПИДа Moscow
Татьяна Евгеньевна КУШАКОВА
ФБУН Центральный НИИ эпидемиологии Роспотребнадзорааспирантка Moscow
Список литературы
- Larranaga G.F., Petroni A., Deluchi G. et al. Viral load and disease progression as responsible for endothelial activation and/or injury in human immunodeficiency virus-1-infected patients. Blood Coagulation & Fibrinolysis 2003; 14(1): 15-18.
- Palella F.J.Jr., Delaney K.M., Moorman A.C. et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. New Engl. J. Med. 1998; 338(13): 853-860.
- Kulasegaram R., Peters B.S., Wierzbicki A.S. Dyslipidaemia and cardiovascular risk in HIV infection. Curr. Med. Res. Opin. 2005; 21(11): 1717-1726.
- The Data Collection on Adverse Events of Anti-HIV drugs (D: A: D) Study Group. Factors associated with specific causes of death amongst HIV-positive individuals in the D: A: D study. AIDS 2010; 24 (10): 1537-1548.
- Dubé M.P., Lipshultz S.E., Fichtenbaum C.J. et al. Effects of HIV Infection and Antiretroviral Therapy on the Heart and Vasculature. Circulation 2008; 118: e36-e40.
- Kaplan R.C., Kim P., Lo J. et al. Prevention Strategies for Cardiovascular Disease in HIV-Infected Patients. Circulation 2008; 118: e54-e60.
- Mondy K., Overton E.T., Grubb J. et al. Metabolic syndrome in HIV-infected patients from an urban, midwestern US outpatient population. Clin. Infect. Dis. 2007; 44(5): 726-734.
- Pao V., Lee G.A., Grunfeld C. HIV therapy, metabolic syndrome, and cardiovascular risk. Сшт. Atheroscler. Rep. 2008; 10(1): 61-70.
- Feingold K., Krauss R., Pang M. et al. The hypertriglyceridemia of acquired immunodeficiency syndrome is associated with an increased prevalence of low density lipoprotein subclass pattern B. J. Clin. Endocrinol. Metab. 1993; 6: 1423-1427.
- Stein J.H., Currier J.S. Risk of myocardial infarction and nucleoside analogues. Lancet 2008; 371: 1391-1392.
- Carr A., Ory D. Does HIV Cause Cardiovascular Disease. PLoS Med. 2006; 3(11): e496.
- El-Sadr W.M., Mullin C.M., Carr A. et al. Effects of HIV disease on lipid, glucose and insulin levels: results from a large antiretroviralnaive cohort. HIV Med., 2005; 6(2): 114-121.
- Petoumenos K., Worm S., Reiss P. et al. Rates of cardiovascular disease following smoking cessation in patients with HIV infection: results from the D: A: D study. Seventeenth Conference on Retroviruses and Opportunistic Infections. San Francisco, 2010, abstract 124.
- Petoumenos K., Worm S., Reiss P. et al. Rates of cardiovascular disease following smoking cessation in patients with HIV infection: results from the D: A: D study. HIV Medicine 2011; 12 (7): 412-421.
- Majluf-Cruz A. Changes in blood coagulation in HIV infection. Rev. Invest. Clin. 1997; 49(1): 51-66.
- Bissuel F., Berruyer M., Causse X. et al. Acquired protein S deficiency: correlation with advanced disease in HIV-I infected patients. J. Acquir. Immune Defic. Syndr. 1992; 5: 484-489.
- Saif M.W., Greenberg B. HIV and thrombosis: a review. AIDS Patient Care STDS. 2001; 15(1): 15-24.
- Feffer S.E., Fox F., Orsen M.M. et al. Thrombotic tendencies and correlation with clinical status in patients infected with HIV. South. Med. J. 1995; 88: 1126-1130.
- Calza L., Pocaterra D., Pavoni M. et al. Plasma Levels of VCAM-1, ICAM-1, E-Selectin, and P-Selectin in 99 HIV-Positive Patients Versus 51 HIV-Negative Healthy Controls. JAIDS (Journal of Acquired Immune Deficiency Syndromes) 2009; 50(4): 430-432.
- Reingold J.S., Wanke K., Kotler D.P. et al. Association of HIV infection and HIV/HCV coinfection with C-reactive protein levels: The Fat Redistribution and Metabolic Change in HIV Infection (FRAM) study. J. Acquir. Immune Defic. Syndr. 2008; 48 (2): 142-148.
- Knobel H., Jerico C., Montero M. et al. Global cardiovascular risk in patients with HIV infection: concordance and differences in estimates according to three risk equations (Framingham, SCORE, and PROCAM). AIDS Patient Care 2007; 21(7): 452-457.
- Kuller L.H., Tracy R., Belloso W. et al. Elevated levels of interleukin-6 and D-dimer are associated with an increased risk of death in patients with HIV. Fifteenth Conference on Retroviruses and Opportunistic Infections. Boston, 2008, abstract 139.
- Currier J.S., Lundgren J.D., Carr A. et al. Epidemiological Evidence for Cardiovascular Disease in HIV-Infected Patients and Relationship to Highly Active Antiretroviral Therapy. Circulation 2008; 118: e29-e35.